| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |